ThromboGenics Receives Positive CHMP Opinion for JETREA®

News   Apr 24, 2013

 
ThromboGenics Receives Positive CHMP Opinion for JETREA®
 
 
 

RELATED ARTICLES

Battling Flames Increases Firefighters’ Exposure to Carcinogens

News

Researchers have measured how much firefighters' exposure to carcinogens and other harmful compounds increases when fighting fires.

READ MORE

DataArt Joins Biotechnology Association BIO Deutschland

News

Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.

READ MORE

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE